You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 海普瑞(9989.HK)暗盤段漲逾3%
格隆匯 07-07 16:23
格隆匯7月7日丨據輝立證券,海普瑞(9989.HK)暗盤段現報18.96港元,較發行價18.4港元漲3.04%。公司是一家制藥公司,按注射製劑的出口價值及出口量計,2018年公司在中國製藥公司中排名第一,且產品主要銷往歐盟市場;公司還是中國最大及全球第三大依諾肝素鈉注射液生產商及銷售商。公司2017年至2019年收益分別為28.28億、47.99億、46.12億元人民幣,溢利分別為2.4億、6.16億、10.43億元人民幣,2019歷史市盈率31.36 - 31.78倍。此次擬全球發售約2.2億股,其中香港發售股份8803.8萬股,國際發售股份約1.32億股,每手500股,淨籌38.057億港元,香港公開發售獲69.21倍認購。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account